{
  "meta": {
    "title": "Thyroid_And_Antithyroid_Drugs",
    "url": "https://brainandscalpel.vercel.app/thyroid-and-antithyroid-drugs-89c42a9a.html",
    "scrapedAt": "2025-11-30T11:19:53.954Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Lanreotide</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Levothyroxine </span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman presents with tachycardia, heat intolerance, tremor, and unintentional weight loss. A thyroid scan shows multiple regions of the thyroid taking up excess iodine. She is prescribed a drug that will decrease the synthesis of thyroid hormones and decrease the peripheral conversion of T4 to T3. Which drug is this?</span></p>",
      "unique_key": "DT1166315",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Propylthiouracil (PTU) is the preferred antithyroid agent in certain clinical situations due to its dual mechanism:</p>\r\n<ul>\r\n<li><strong>Inhibits thyroid peroxidase</strong>, thereby blocking organification and coupling steps in thyroid hormone synthesis.</li>\r\n<li><strong>Inhibits peripheral conversion of T4 to T3</strong>, which is especially useful in severe thyrotoxicosis and thyroid storm.</li>\r\n<li>Methimazole and propylthiouracil both decrease the synthesis of thyroid hormone, but only propylthiouracil decreases the peripheral conversion of T4 to T3.\r\n<ul>\r\n<li>These drugs both inhibit thyroid peroxidase, which is the enzyme responsible for oxidation and organification of iodide for its incorporation into T3 and T4. Because it also inhibits peripheral conversion to T3, propylthiouracil may be preferred in severe hyperthyroidism.</li>\r\n</ul>\r\n</li>\r\n<li>Lanreotide is a somatostatin analogue used in secondary hyperthyroidism because somatostatin normally inhibits TSH secretion.</li>\r\n<li>Levothyroxine is a synthetic T4. It is used to treat hypothyroidism and would worsen this patient&rsquo;s condition.</li>\r\n<li>Methimazole decreases the synthesis of thyroid hormone but does not decrease the peripheral conversion of T4 to T3. Octreotide is a somatostatin analogue used in secondary hyperthyroidism because somatostatin normally inhibits TSH secretion.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Lanreotide (Option A):</strong>  Somatostatin analogue; inhibits TSH secretion, but is not used for primary hyperthyroidism.</p>\r\n<p><strong>Levothyroxine (Option B):</strong>  Synthetic T4; used in hypothyroidism, would worsen this patient's condition.</p>\r\n<p><strong>Methimazole (Option C):</strong> Inhibits thyroid peroxidase but does <strong>not</strong>  inhibit peripheral T4 to T3 conversion.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Celiac disease</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Medication noncompliance</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Poor absorption of levothyroxine due to ferrous sulfate</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH-secreting pituitary adenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old woman with longstanding hypothyroidism was diagnosed with uterine fibroids and started on iron recently. Her other medications include levothyroxine, atorvastatin, and hydrochlorothiazide. A TSH is checked, and it is elevated to 15 mU/L. Which of the following is the most likely reason for her elevated TSH?</span></p>",
      "unique_key": "DT1166318",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166318,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>TSH elevation in a patient stable on levothyroxine suggests an issue with absorption or drug interaction. Ferrous sulfate is a known interfering agent that impairs the gastrointestinal absorption of levothyroxine.</p>\r\n<ul>\r\n<li><strong>Levothyroxine</strong>absorption occurs in the duodenum and jejunum and is impaired by iron salts such as <strong>ferrous sulfate</strong>.</li>\r\n<li>TSH elevation may occur despite compliance if <strong>concomitant administration of interfering drugs</strong></li>\r\n<li><strong>Iron salts</strong>are among the factors that <strong>increase levothyroxine dosage requirements</strong>  by reducing absorption.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510015ef65a62-8ab5-4295-b6ad-3233e5b2dbe7.png\">\r\n </li>\r\n<li>An increase in TSH in a patient with hypothyroidism that was previously stable with medication for many years suggests either a failure to take the medication, difficulty with absorption from bowel disease, medication interaction or drug-drug interaction affecting clearance.</li>\r\n<li>In patients with normal body weight taking &gt;200 &mu;g of levothyroxine per day, an elevated TSH strongly suggests noncompliance. Such patients should be encouraged to take two tablets at one time on the day they remember to attempt to reach the weekly target dose; the long drug half-life makes this practice safe.</li>\r\n<li>Other causes of increased thyroxine requirements include malabsorption, such as with celiac disease or small bowel surgery, estrogen therapy, and drugs that interfere with T4 absorption (e.g., ferrous sulfate, cholestyramine) or clearance (e.g., lovastatin, amiodarone, carbamazepine, phenytoin).</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Celiac disease (Option A):</strong>  Can impair absorption, but would also present with other systemic signs and takes time to develop. Less likely than a recent drug interaction.</p>\r\n<p><strong>Medication noncompliance (Option B):</strong> Would typically be suspected if TSH elevation is seen despite no recent change in therapy or addition of new medications.</p>\r\n<p><strong>TSH-secreting pituitary adenoma (Option D):</strong> Rare and typically presents with <strong>high T3/T4 with inappropriately normal or elevated TSH</strong>, not isolated elevated TSH.</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">External warming is a critical feature of therapy in patients with a temperature &lt; 34C.</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypotonic intravenous solutions should be avoided.</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous (IV) levothyroxine should be administered with IV glucocorticoids.</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">This condition occurs almost exclusively in the elderly and often is precipitated by an unrelated medical illness.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 92-year-old woman is admitted to the ICU with depressed consciousness, hypothermia, sinus bradycardia, hypotension, and hypoglycemia. She has a history of hypothyroidism and hypertension. Lab reports show serum sodium of 129 mmol/L, glucose 48 mg/dL, and TSH >100 mIU/L. Which of the following statements regarding this condition is false?</span></p>",
      "unique_key": "DT1166320",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166320,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Myxedema coma </strong>is a life-threatening expression of long-standing hypothyroidism most commonly seen in the<strong> elderly</strong>, typically precipitated by<strong>  infections, myocardial infarction, or other systemic illnesses. External warming should be used with caution</strong>, as it may precipitate cardiovascular collapse. <strong>Passive rewarming is preferred over aggressive external warming.</strong></p>\r\n<ul>\r\n<li><strong>Typical features:</strong>Hypothermia, altered consciousness, bradycardia, hypotension, and hypoglycemia.</li>\r\n<li><strong>Precipitating factors:</strong>Infection, congestive heart failure, narcotic use, and cold exposure.</li>\r\n<li><strong>Therapy includes:</strong>\r\n<ul>\r\n<li><strong>IV levothyroxine</strong>for thyroid hormone repletion</li>\r\n<li><strong>IV glucocorticoids</strong>to address possible adrenal insufficiency</li>\r\n<li><strong>Avoiding hypotonic solutions,</strong>which can worsen hyponatremia</li>\r\n<li><strong>Supportive care</strong>, careful fluid management, and cautious warming (external warming may worsen hypotension)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Hypotonic intravenous solutions should be avoided (Option B):</strong>  May worsen hyponatremia or lead to fluid overload.</p>\r\n<p><strong>IV levothyroxine with IV glucocorticoids (Option C):</strong> Recommended due to the risk of adrenal insufficiency.</p>\r\n<p><strong>Occurs in the elderly and is often precipitated by illness (Option D):</strong> Frequently triggered by systemic insults in the elderly.</p>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Accelerating the peripheral metabolism of T3</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting the proteolysis of thyroid-binding globulin</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting the uptake of iodide by cells in the thyroid </span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Preventing the addition of iodine to tyrosine residues on thyroglobulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old woman was found to have mild hyperthyroidism due to Graves disease. She appears to be in good health otherwise. The decision is made to begin treatment with methimazole. It reduces serum concentration of T3 primarily by which of the following mechanisms?</span></p>",
      "unique_key": "DT1166322",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166322,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Methimazole and propylthiouracil are antithyroid drugs classified as thioamides.</p>\r\n<p>They inhibit thyroid hormone synthesis by blocking thyroid peroxidase&ndash;mediated reactions.</p>\r\n<ul>\r\n<li>This action prevents <strong>oxidation of iodide</strong>and <strong>organification</strong>, thereby stopping the incorporation of iodine into tyrosine residues of thyroglobulin.</li>\r\n<li>As a result, production of monoiodotyrosine (MIT) and diiodotyrosine (DIT) is impaired, which are essential precursors of thyroid hormones T3 and T4.</li>\r\n<li>This mechanism decreases the formation and eventual secretion of T3 and T4, helping in the management of hyperthyroidism.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510019e13fbad-977c-4414-8159-1b9fa4143e9f.png\">\r\n \r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403257909598b-6610-436e-abe0-b84663b256d7.jpg\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Accelerating the peripheral metabolism of T3 (Option A):</strong>  Not a mechanism of thioamides. PTU blocks the conversion of T4 to T3, but not via enhanced T3 metabolism.</p>\r\n<p><strong>Inhibiting the proteolysis of thyroid-binding globulin (Option B):</strong>   Thioamides act on thyroid hormone synthesis, not on binding globulins.</p>\r\n<p><strong>Inhibiting the uptake of iodide by cells in the thyroid (Option C):</strong> Iodide uptake is blocked by ionic inhibitors (e.g., perchlorate, thiocyanate), not by methimazole.</p>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Levothyroxine </span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Lugol's solution </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisone</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman with multinodular goitre (MNG) is scheduled for a total thyroidectomy. Which of the following drugs is administered for 10-14 days preoperatively to reduce the vascularity of the thyroid gland?</span></p>",
      "unique_key": "DT1166323",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Lugol&rsquo;s solution</strong>, which contains <strong>elemental iodine and potassium iodide</strong>, is used preoperatively for thyroidectomy to reduce thyroid gland vascularity and hormone synthesis.</p>\r\n<ul>\r\n<li><strong>Mechanism of action:</strong>\r\n<ul>\r\n<li>It decreases the size, vascularity, and friability of the hyperplastic thyroid gland.</li>\r\n<li>It acutely inhibits the organification and release of thyroid hormone from the thyroid gland.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Use:</strong>\r\n<ul>\r\n<li>Commonly administered for 10-14 days before surgery to facilitate a safer thyroidectomy.</li>\r\n<li>Its effects begin within 1-2 days and peak around 10-14 days.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Caution:</strong>\r\n<ul>\r\n<li>Should not be used long-term as it may lead to an 'escape phenomenon' where hormone synthesis resumes.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001bfa7be30-ed2a-432c-aea9-59185c1ea09a.png\">\r\n ",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease the dose of methimazole</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue methimazole</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Switch to PTU</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\"> Conservative management</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old woman recently diagnosed with Graves' disease presents with fever, malaise, chills, and sore throat. She was started on methimazole 2 weeks ago. Her laboratory investigations reveal the following:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240322e39b7ebe-782b-42e6-b47d-e87c3f37e529.jpg\"><br>Which of the following actions by the physician is most appropriate?</span></p>",
      "unique_key": "DT1166324",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166324,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient presents with signs of infection and neutropenia, a known early adverse effect of methimazole. The absolute neutrophil count (ANC) here is <strong>8% of 3000 = 240/mm&sup3;</strong>, indicating <strong>agranulocytosis</strong> (&lt;500/mm&sup3;), a medical emergency.</p>\r\n<ul>\r\n<li>Methimazole-induced agranulocytosis typically occurs <strong>within 2-12 weeks</strong>of therapy.</li>\r\n<li>Symptoms include <strong>fever, malaise, and sore throat</strong>, which precede or coincide with neutropenia.</li>\r\n<li>Once agranulocytosis is confirmed or strongly suspected, the drug must be <strong>immediately discontinued</strong>.</li>\r\n<li><strong>Switching to PTU is not recommended</strong>, as it has a similar risk of agranulocytosis.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001750e73d8-2e5f-400b-b2e3-135b995a9bd8.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Decrease the dose of methimazole (Option A):</strong>    Not sufficient or safe; agranulocytosis is idiosyncratic and unrelated to dose.</p>\r\n<p><strong>Switch to PTU (Option C):</strong>  Contraindicated due to shared risk profile.</p>\r\n<p><strong>Conservative management (Option D):</strong>   Delaying drug cessation risks septic complications</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">KI</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">PTU</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexrazoxane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old woman is brought to the emergency department after an accidental ingestion of a large dose of radioactive iodine. Which of the following pharmacologic agents should be administered immediately to prevent complications from this exposure?</span></p>",
      "unique_key": "DT1166326",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166326,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Potassium iodide (KI)</strong> should be administered immediately to reduce the risk of radiation-induced thyroid damage.</p>\r\n<ul>\r\n<li>KI blocks the uptake of radioactive iodine (&sup1;&sup3;&sup1;I) by saturating the thyroid gland with stable iodine, thus preventing the accumulation of radioactive isotopes.</li>\r\n<li>It acts by acutely inhibiting the synthesis and release of thyroid hormones, known as the <strong>Wolff-Chaikoff effect</strong>.</li>\r\n<li>This protective effect is effective if administered within hours of exposure.</li>\r\n<li>KI is also used in hyperthyroidism and thyroid storm management due to its inhibitory action on thyroid hormone release.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100150452db5-7b14-4aef-bceb-28897d61b6e9.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>PTU (Option B):</strong> Antithyroid drug that inhibits thyroid peroxidase and peripheral T4&rarr;T3 conversion; not effective in immediate blocking of &sup1;&sup3;&sup1;I uptake.</p>\r\n<p><strong>Methimazole (Option C):</strong> Inhibits thyroid peroxidase; not effective in emergency radioactive iodine exposure.</p>\r\n<p><strong>Dexrazoxane (Option D):</strong> Iron-chelating agent used to prevent anthracycline-induced cardiotoxicity; not relevant here.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Lugol's iodine</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">PTU</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old woman at 8 weeks of gestation presents with progressive fatigue for 1 month. She has had a 3.2-kg weight loss despite increased appetite, insomnia, and heightened anxiety. Her eyes are prominent, and the thyroid is diffusely enlarged. Serum TSH is 0.1 &mu;U/mL. What is the most appropriate next step in management?</span></p>",
      "unique_key": "DT1166327",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166327,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>PTU (propylthiouracil) is the preferred treatment during the first trimester of pregnancy in Graves' disease. Methimazole is avoided in early pregnancy due to teratogenicity, whereas PTU has a lower placental transfer rate and reduced risk of embryopathy.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001c749e92e-c8b2-45c7-9b0f-2a38bd008b3b.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Lugol's iodine (Option A):</strong> Used preoperatively for thyroidectomy; contraindicated in the first trimester due to transient suppression followed by rebound thyrotoxicosis.</p>\r\n<p><strong>Atenolol (Option C):</strong> Avoided in pregnancy due to risk of fetal growth restriction; beta-blockers like propranolol are preferred if needed.</p>\r\n<p><strong>Methimazole (Option D):</strong> Teratogenic in the first trimester; not used due to risk of congenital malformations.</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Flare-up of exophthalmos</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Seizures</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolysis</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Overstimulation of the heart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Initiating T4 therapy for an elderly patient with long-standing hypothyroidism, it is important to begin with small doses to avoid which of the following?</span></p>",
      "unique_key": "DT1166332",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166332,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>T4 therapy should be initiated cautiously in elderly hypothyroid patients to avoid cardiac overstimulation.</strong></p>\r\n<ul>\r\n<li>Elderly individuals and patients with long-standing hypothyroidism are highly sensitive to the cardiovascular effects of levothyroxine.</li>\r\n<li>These patients may have decreased cardiac reserve and underlying ischemic heart disease, making them vulnerable to arrhythmias and cardiac failure.</li>\r\n<li>Therapy should be initiated with a low dose (e.g., 12.5-25 &mu;g/day) and titrated gradually based on TSH and clinical response.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001d31a978c-9c1f-4040-be2b-07579e721386.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Flare-up of exophthalmos (Option A):</strong> Seen in hyperthyroidism (especially Graves'disease), not relevant to T4 therapy in hypothyroid patients.</p>\r\n<p><strong>Seizures (Option B):</strong> Not a typical complication of T4 initiation in hypothyroidism.</p>\r\n<p><strong>Hemolysis (Option C):</strong> Not associated with thyroid hormone replacement therapy.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">I131</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiocyanate (SCN ) </span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old woman presents with the complaint of 'something wrong with her heart, heart jumping out of her chest.' Lab tests confirm hyperthyroidism. Which of the following is a drug that produces a permanent reduction in thyroid activity?</span></p>",
      "unique_key": "DT1166333",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166333,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Radioactive iodine (I131)</strong> is the <strong>only medical therapy that produces a permanent reduction in thyroid activity</strong>.</p>\r\n<ul>\r\n<li>I131 destroys thyroid tissue via &beta;-particle emission, taken up into follicular cells via <strong>sodium/iodine symporter (NIS)</strong>.</li>\r\n<li><strong>Gamma rays</strong>: diagnostic utility</li>\r\n<li><strong>Beta rays</strong>: therapeutic utility</li>\r\n</ul>\r\n<h4><strong>Indications:</strong></h4>\r\n<ul>\r\n<li>Toxic multinodular goitre (MNG) and toxic adenoma with high radioactive iodine uptake</li>\r\n<li>Graves' disease not controlled with antithyroid drugs (ATDs) due to:\r\n<ul>\r\n<li>Refractory hyperthyroidism</li>\r\n<li>Contraindications to ATDs (e.g., liver disease)</li>\r\n<li>Severe adverse effects from ATDs</li>\r\n<li>High surgical risk (due to comorbidities, previous neck surgery/radiation)</li>\r\n<li>Limited life expectancy</li>\r\n</ul>\r\n</li>\r\n<li>Thyrotoxic periodic paralysis</li>\r\n<li>Large or compressive nontoxic goitre</li>\r\n<li>Postoperative treatment of certain thyroid malignancies</li>\r\n</ul>\r\n<h4><strong>Contraindications:</strong></h4>\r\n<ul>\r\n<li>Pregnancy or breastfeeding</li>\r\n<li>Children &lt; 5 years of age</li>\r\n<li>Initial treatment for suspected/confirmed thyroid malignancy</li>\r\n<li>Moderate to severe Graves ophthalmopathy</li>\r\n<li>Inability to follow radiation safety precautions</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Propylthiouracil (Option B):</strong> Reversible antithyroid drug; inhibits TPO and peripheral T4&rarr;T3 conversion. Does not destroy thyroid tissue.</p>\r\n<p><strong>Thiocyanate (Option C):</strong> An Anion inhibitor that blocks iodide uptake via NIS; rarely used due to <strong>unpredictable efficacy</strong>.</p>\r\n<p><strong>Propranolol (Option D):</strong> Used for <strong>symptom control</strong> (palpitations, tremor); blocks peripheral conversion of T4 to T3 but has no impact on hormone synthesis or gland structure.</p>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine </span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman presents with complaints of fatigue, sluggishness, and weight gain. She has been taking T4 for the past 5 years without significant problems regarding her energy level. Her recent history is significant for a diagnosis of arrhythmia, and she is currently taking an anti-arrhythmic drug. What is the most likely cause of her current condition?</span></p>",
      "unique_key": "DT1166335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Amiodarone is an iodine-containing anti-arrhythmic agent that causes thyroid dysfunction due to its high iodine content and complex interactions with thyroid hormone synthesis and metabolism.</p>\r\n<ul>\r\n<li>Each 200 mg tablet of amiodarone contains about <strong>75 mg of iodine</strong>, of which <strong>6-8 mg is released daily</strong>, far exceeding daily iodine requirements.</li>\r\n<li>Amiodarone can cause <strong>hypothyroidism (Type 2)</strong>due to destructive thyroiditis or <strong>hyperthyroidism (Type 1)</strong> in patients with pre-existing thyroid disease.</li>\r\n<li>It also <strong>inhibits peripheral conversion</strong>of T4 to T3, further contributing to hypothyroid symptoms like fatigue and weight gain.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001c156aca7-58d0-471d-b739-6d3271289cef.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Lidocaine (Option B):</strong> Class IB antiarrhythmic; no known effect on thyroid function.</p>\r\n<p><strong>Procainamide (Option C):</strong> Class IA antiarrhythmic; may cause SLE-like syndrome but does not affect thyroid hormones.</p>\r\n<p><strong>Verapamil (Option D):</strong> Calcium channel blocker; used for rate control in arrhythmias; does not affect thyroid function.</p>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">T3</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">T4</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">FSH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old woman underwent near-total thyroidectomy. She was started on levothyroxine. What hormone is produced in the peripheral tissues when levothyroxine is administered?</span></p>",
      "unique_key": "DT1166337",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166337,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Levothyroxine (L-thyroxine)</strong> is a <strong>synthetic form of T4</strong> and is the<strong> drug of choice</strong> for replacement therapy in <strong>hypothyroidism and myxedema</strong>. After absorption, it is <strong>peripherally converted</strong>  into the <strong>biologically active hormone T3 and the inactive form rT3</strong>.</p>\r\n<ul>\r\n<li>T3 is the active thyroid hormone responsible for the majority of thyroid hormone effects.</li>\r\n<li>Levothyroxine therapy maintains consistent serum T4 levels and relies on peripheral conversion to achieve euthyroidism.</li>\r\n<li>Side effects of levothyroxine (especially in overdose or hyperthyroid states) include:\r\n<ul>\r\n<li>Sweating, heat intolerance</li>\r\n<li>Tachycardia, palpitations, arrhythmias, chest pain</li>\r\n<li>Tremors</li>\r\n<li>Weight loss (can be misused for weight reduction)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100181c86187-81c6-4052-a714-b83e09f73961.png\">\r\n \r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>T4 (Option B):</strong> The administered form, but not the biologically active hormone; it requires conversion to T3.</p>\r\n<p><strong>TSH (Option C):</strong> Suppressed via negative feedback from adequate/excess T4/T3 levels.</p>\r\n<p><strong>FSH (Option D):</strong> Follicle-stimulating hormone; unrelated to thyroid physiology.</p>",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole and propranolol therapy</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium iodide therapy</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Dextrose therapy</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Ampicillin and gentamycin therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-day-old newborn is becoming increasingly irritable and has had 10 bowel movements over the past 2 days. He was born at 38 weeks'gestation and weighed 1800 g; he currently weighs 1700 g. His mother has Graves' disease and received propylthiouracil during the last trimester of pregnancy. Examination shows mild diaphoresis and a firm 2-cm midline neck swelling. Which of the following is the most appropriate next step in management?</span></p>",
      "unique_key": "DT1166338",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Neonatal thyrotoxicosis</strong> occurs due to transplacental passage of maternal TSH receptor-stimulating antibodies (TRAb), especially in mothers with active or treated Graves' disease.</p>\r\n<ul>\r\n<li><strong>Onset is often delayed</strong>until 7-10 days postpartum due to the suppressive effects of maternal antithyroid drugs like propylthiouracil.</li>\r\n<li><strong>Symptoms</strong>: Irritability, diaphoresis, goitre, tachycardia, increased bowel movements, and poor weight gain despite adequate feeding.</li>\r\n<li><strong>Complications</strong>: If untreated, it may lead to cardiac failure, craniosynostosis, and neurodevelopmental delay.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001f89584d3-aee7-4c4e-a042-77d8a362bdf7.png\">\r\n </li>\r\n<li>Methimazole and propranolol together form the cornerstone of treatment.</li>\r\n<li>Therapy is continued until the maternal antibodies clear from circulation, usually by <strong>12 weeks</strong></li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Potassium iodide therapy (Option B):</strong> Not used as first-line in neonates; typically adjunctive in thyroid storm or pre-op.</p>\r\n<p><strong>Dextrose therapy (Option C):</strong> May be supportive, but does not address underlying thyrotoxicosis.</p>\r\n<p><strong>Ampicillin and gentamicin therapy (Option D):</strong> Indicated for neonatal sepsis; not applicable in thyrotoxicosis.</p>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Betamethasone </span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Epinephrine</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman presents with tachycardia, shortness of breath, and chest pain. She had had shortness of breath and diarrhoea for the last 2 days and was sweating and anxious. TSH <0.01 mIU/L (normal 0.4-4.0 mIU/L). The diagnosis of thyroid storm was made. Which of the following is a drug that is a useful adjuvant in the treatment of thyroid storm?</span></p>",
      "unique_key": "DT1166340",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166340,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Propranolol</strong> is a first-line adjuvant in thyroid storm due to its <strong>dual benefit</strong>:</p>\r\n<ul>\r\n<li><strong>Beta-adrenergic blockade</strong>to control tachycardia, palpitations, anxiety, and tremors</li>\r\n<li><strong>Inhibits peripheral conversion of T4 to T3</strong>, thus decreasing circulating active hormone levels</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001f14fe32b-9014-4abc-997f-d8f544307008.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Amiodarone (Option A):</strong> Can induce both hypothyroidism and thyrotoxicosis due to high iodine content; not used in thyroid storm treatment.</p>\r\n<p><strong>Betamethasone (Option B):</strong> A glucocorticoid, but hydrocortisone is preferred due to its mineralocorticoid activity.</p>\r\n<p><strong>Epinephrine (Option C):</strong> Contraindicated as it worsens adrenergic symptoms; may precipitate arrhythmias.</p>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Near-total thyroidectomy</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium iodide therapy</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole therapy</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">L-thyroxine therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman presents with a gradually enlarging anterior neck swelling. On examination, a diffuse, soft goitre is palpated. Laboratory investigations reveal suppressed TSH and elevated T3 and T4 levels. Anti-TSH receptor antibodies are positive. Thyroid scintigraphy is shown below. She is administered a single oral dose of radioactive iodine. Which of the following is the most likely long-term treatment required in this patient?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240322a1bec585-2c39-4ee2-8895-386e101e95ec.jpg\"></span></p>",
      "unique_key": "DT1166343",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166343,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient has <strong>Graves' disease</strong>, indicated by suppressed TSH, elevated thyroid hormones, positive TSH receptor antibodies, and a scintigraphy scan showing <strong>diffuse, homogeneous uptake</strong> of radioactive iodine.</p>\r\n<ul>\r\n<li><strong>Radioactive Iodine Ablation (RAIA)</strong>is selectively taken up by the hyperfunctioning thyroid tissue and gradually destroys it.</li>\r\n<li>As the entire thyroid gland is overactive in Graves' disease, the destruction is often <strong>complete</strong>, resulting in <strong>permanent hypothyroidism</strong>.</li>\r\n<li>Hence, most patients require <strong>lifelong L-thyroxine replacement</strong>following RAI therapy.</li>\r\n</ul>\r\n<p>RAIA is a definitive treatment for Graves' disease. However, because the entire gland is irradiated, the majority of patients develop hypothyroidism requiring lifelong levothyroxine therapy.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025100138e92d2b-1ec1-47e7-ac59-a05d1a4dae76.png\">",
      "correct_choice_id": 144,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Subtotal thyroidectomy</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine ablation</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium iodide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old woman presents with a diffusely enlarged thyroid gland with no palpable nodules. Serum studies show a TSH concentration of 0.2 &mu;U/mL, thyroxine (T4) concentration of 24 &mu;g/dL, and positive antibodies against the TSH receptor. Which of the following treatment modalities is associated with the lowest rate of recurrence for this patient's condition?</span></p>",
      "unique_key": "DT1166345",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166345,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Radioactive iodine ablation (RAIA) achieves the lowest recurrence rates in Graves' disease by selectively destroying hyperfunctioning thyroid tissue.</p>\r\n<ul>\r\n<li><strong>Graves' disease</strong>involves diffuse hyperactivity of the thyroid gland due to TSH-receptor stimulating antibodies.</li>\r\n<li><strong>RAIA with I&sup1;&sup3;&sup1;</strong>concentrates in the overactive thyroid follicles, emits &beta;-radiation, and destroys thyroid tissue.</li>\r\n<li>It is administered orally and leads to a <strong>permanent cure</strong>in most cases by destroying all functioning thyroid tissue.</li>\r\n<li><strong>Hypothyroidism</strong>is a common consequence and usually requires <strong>lifelong L-thyroxine replacement</strong>.</li>\r\n<li>Compared to antithyroid drugs (e.g., methimazole) or surgery (e.g., subtotal thyroidectomy), RAIA has <strong>lower recurrence</strong>and is preferred when rapid, definitive therapy is desired.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001ac79d5d1-d9fa-4144-ac4d-1fa36d77b927.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Subtotal thyroidectomy (Option A):</strong> Though more definitive than medical therapy, it is associated with surgical risks and possible recurrence from remnant thyroid tissue.</p>\r\n<p><strong>Methimazole (Option C):</strong> Effective short-term, but recurrence is common after discontinuation.</p>\r\n<p><strong>Potassium iodide (Option D):</strong> Used acutely in thyroid storm or before surgery; not a long-term therapy and not curative.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">RAIA</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Near total thyroidectomy</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Tocilizumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman comes with retraction of the upper eyelids, anterior protrusion of both eyeballs, and restricted convergence during accommodation reflex testing. Serum studies show a thyroid-stimulating hormone concentration of 0.03&mu;U/mL, thyroxine concentration of 19 &mu;g/dL, and antibodies against the TSH receptor. Thyroid scintigraphy shows diffusely increased iodine uptake. Treatment with propranolol is initiated. Which of the following is the most appropriate next step in treatment?</span></p>",
      "unique_key": "DT1166348",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166348,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient presents with classic features of <strong>Graves' disease (GD)</strong> and associated <strong>Graves orbitopathy (GO)</strong>. In the setting of moderate-to-severe GO, the next step after initial symptomatic control with propranolol is <strong>methimazole</strong>, an antithyroid drug.</p>\r\n<ul>\r\n<li><strong>Methimazole</strong>inhibits thyroid hormone synthesis and is used to establish euthyroidism before considering long-term treatments.</li>\r\n<li><strong>RAIA</strong>is <strong>not recommended</strong> in patients with moderate-to-severe GO, as it can exacerbate orbitopathy.</li>\r\n<li><strong>Tocilizumab</strong>is reserved for <strong>refractory GO</strong>, not first-line.</li>\r\n<li><strong>Thyroidectomy</strong>may be an option, but it is typically considered <strong>after</strong> failure or intolerance to antithyroid drugs or RAIA in patients without orbitopathy</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510016c27e9b7-20b8-4adc-83e6-aa3831796564.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>RAIA (Option A):</strong> Contraindicated in moderate-to-severe orbitopathy due to the risk of worsening symptoms.</p>\r\n<p><strong>Near-total thyroidectomy (Option C):</strong> More invasive; considered after failure of medical management or intolerance.</p>\r\n<p><strong>Tocilizumab (Option D):</strong> Reserved for steroid-refractory GO; not first-line after propranolol.</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue current medication</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Check for visual field disturbance</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue same treatment</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Add glucocorticoids in current treatment regimen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman with septic shock has persistent hypotension. Her blood cultures were initially positive for E. coli. She is currently on norepinephrine, ceftriaxone, and acetaminophen. Repeat blood cultures are now negative. Her temperature is 99.5&deg;F, heart rate is 96/min, and blood pressure is 90/60 mmHg. Laboratory studies are shown below:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403226809c5d5-0b71-4027-bc72-5685cd3e856d.jpg\"></span></p>",
      "unique_key": "DT1166357",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166357,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient has persistent hypotension from a resolving septic infection, but her lab parameters indicate steady improvement. She demonstrates a classic pattern of <strong>Sick Euthyroid Syndrome (SES)</strong> or <strong>Non-thyroidal Illness Syndrome (NTIS)</strong>:</p>\r\n<ul>\r\n<li>Low T3</li>\r\n<li>Normal to low-normal TSH</li>\r\n<li>Normal free T4</li>\r\n</ul>\r\n<p>This pattern is seen in critically ill patients with <strong>intact thyroid function</strong>, and the abnormalities are <strong>secondary to illness</strong>, not intrinsic thyroid pathology.</p>\r\n<h4><strong>Pathophysiology:</strong></h4>\r\n<ul>\r\n<li><strong>&darr; Type 1 deiodinase</strong>&rarr; &darr; peripheral T4 to T3 conversion</li>\r\n<li><strong>&uarr; Type 3 deiodinase</strong>&rarr; &uarr; degradation of T3 to inactive forms (rT3)</li>\r\n<li><strong>Type 2 deiodinase</strong>in the <strong>pituitary remains functional</strong>, maintaining pituitary T3 levels &rarr; <strong>TSH remains normal or slightly low</strong></li>\r\n<li>Therefore, there is <strong>no true hypothyroidism</strong>, and TSH stimulation does not increase</li>\r\n</ul>\r\n<p><strong>Management involves treating the underlying condition</strong> (sepsis in this case).</p>\r\n<p><strong>Thyroid hormone replacement is not recommended</strong>, as studies have not shown any consistent clinical benefit in NTIS/ESS.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Discontinue current medication (Option A):</strong> Not indicated. The patient is improving on the current treatment.</p>\r\n<p><strong>Check for visual field disturbance (Option B):</strong> Not relevant to NTIS. Applies to pituitary macroadenomas.</p>\r\n<p><strong>Add glucocorticoids (Option D):</strong> Not required unless adrenal insufficiency is suspected, which is not the case here.</p>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,7</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">2,3,5,6,7</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">3,4,5,6,7</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">1,3,4,6,7</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old woman presents with lethargy and confusion. She is oriented only to person. Her temperature is 94.6&deg;F, pulse rate 49/min, respirations are 9/min, and blood pressure is 90/60 mm Hg. The pupils are 7 mm and reactive to light. Deep tendon reflexes are 1+ bilaterally. Physical examination shows periorbital oedema, non-pitting oedema in both lower extremities, and healed needle track marks in both antecubital fossae. Serum studies show a sodium concentration of 131 mEq/L, a potassium concentration of 4.9 mEq/L, and a glucose concentration of 54 mg/dL. Arterial blood gas analysis on room air is shown below. An ECG shows bradycardia, low voltage QRS complex, and widespread T-wave inversion. Which of the following is the most appropriate management?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202403224cf3ea5a-bcb4-4ea5-849a-a42814c2a81f.jpg\"><br>1.\tNaloxone<br>2.\tSodium bicarbonate<br>3.\tHydrocortisone<br>4.\tLiothyronine<br>5.\tLevothyroxine<br>6.\tEpinephrine<br>7.\tIV fluids</span></p>",
      "unique_key": "DT1166365",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Altered mental status in combination with hypothermia, bradypnea (causing respiratory acidosis with hypoxemia due to hypoventilation), hypotension, bradycardia, and features of <strong>myxedema heart disease </strong>(low-voltage QRS complexes, flattened or inverted T waves) and non-printing oedema is suggestive of <strong>myxedema coma</strong>. Hyponatremia and hypoglycemia can be due to <strong>myxedema coma</strong>   itself or a <strong>concomitant adrenal insufficiency</strong>.</p>\r\n<ul>\r\n<li>Treatment with<strong>liothyronine and levothyroxine</strong>  should be started immediately upon clinical suspicion of myxedema coma because this condition can be life-threatening (up to 50% mortality); patients should also be treated with <strong>glucocorticoids</strong>  until a diagnosis of coexisting adrenal insufficiency is ruled out.</li>\r\n<li>This patient probably had a longstanding, undiagnosed or untreated hypothyroidism, which increases the risk of developing myxedema coma.</li>\r\n<li>Moreover, her presumed history of injection drug use (healed needle track marks) is an additional precipitating factor for this condition.</li>\r\n<li>Other triggers include infections, stroke, acute coronary syndrome, trauma, and surgical procedures.</li>\r\n<li>In patients with suspected myxedema coma, blood samples for evaluation of TSH, T4, and cortisol levels should be drawn before initiating treatment.</li>\r\n<li>The treatment must then be initiated without waiting for the results.</li>\r\n<li><strong>Naloxone (Option 1):</strong>Not appropriate unless opioid overdose is suspected.</li>\r\n<li><strong>Sodium bicarbonate (Option 2):</strong>Metabolic acidosis is not present; the primary problem is respiratory acidosis.</li>\r\n<li><strong>Hydrocortisone (Option 3):</strong>To cover possible adrenal insufficiency.</li>\r\n<li><strong>Liothyronine (Option 4):</strong>Rapid onset T3 therapy.</li>\r\n<li><strong>Levothyroxine (Option 5): </strong>Long-acting T4 support.</li>\r\n<li><strong>Epinephrine (Option 6):</strong>For bradycardia and hypotension.</li>\r\n<li><strong>IV fluids (Option 7):</strong>For hypotension and hypovolemia.</li>\r\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisone</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Ibuprofen</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgery</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">L-thyroxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old woman presents with a pins-and-needles sensation in her hand that worsens at night and is relieved by shaking her hand. She also reports episodic left knee pain during the day. She is on medication for constipation. Her BMI is 35 kg/m2. Vitals reveal pulse 57/min and blood pressure 120/75 mmHg. On examination, sensation is decreased to light touch in the thumb and index finger. Deep tendon reflexes are 1+, and there is mild bilateral leg oedema. Which of the following treatments is most likely to benefit this patient?</span></p>",
      "unique_key": "DT1166369",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166369,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient has clinical features of hypothyroidism - constipation, bradycardia, hyporeflexia, oedema, and obesity - along with median nerve compression, suggesting <strong>carpal tunnel syndrome (CTS)</strong>&nbsp;due to <strong>hypothyroidism</strong>. Levothyroxine therapy treats the underlying cause.</p>\r\n<ul>\r\n<li>The patient presents with classic signs of hypothyroidism: constipation, fatigue, bradycardia, hyporeflexia, and lower limb oedema (which is usually myxedematous and non-pitting, but pitting oedema can also occur due to excessive albumin in extracellular spaces).</li>\r\n<li>While the precise etiopathology is uncertain, it is assumed that the excess deposition of glycosaminoglycans, hyaluronic acid, and mucopolysaccharides in hypothyroidism causes myxedema.</li>\r\n<li>These characteristic depositions can subsequently cause compression of the carpal tunnel. With thyroid hormone replacement and return to a euthyroid state, symptoms should improve within weeks to months.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510010a7564c1-a31a-4494-997e-4ed3c7075594.png\"></li>\r\n<li><strong>Hypothyroidism can lead to carpal tunnel syndrome</strong>due to the <strong>accumulation of mucopolysaccharides and glycosaminoglycans</strong>  in perineural tissues.</li>\r\n<li><strong>Levothyroxine</strong>, a synthetic T4 preparation, corrects the metabolic and neuromuscular manifestations of hypothyroidism, including CTS</li>\r\n<li>Symptom resolution may occur within <strong>weeks to months</strong>of therapy.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Prednisone (Option A):</strong> Used in inflammatory or autoimmune neuropathies; not first-line for CTS due to hypothyroidism.</p>\r\n<p><strong>Ibuprofen (Option B):</strong>  Temporary analgesia; does not address the underlying aetiology.</p>\r\n<p><strong>Surgery (Option C):</strong>Reserved for refractory CTS or severe nerve compression; not first-line in hypothyroid-induced CTS.</p>",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiamine</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Rivastigmine</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">L-thyroxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 73-year-old woman is brought to you for progressive memory loss. She has gained 10 kg over the past year. Her father died due to complications of Alzheimer's disease. She is oriented but has short-term memory deficits. On examination, she has a normal gait and delayed relaxation of the Achilles reflex bilaterally. Her skin is dry, and her nails are brittle. Which of the following is the most appropriate treatment?</span></p>",
      "unique_key": "DT1166371",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166371,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This elderly woman has clinical signs of hypothyroidism, including memory impairment, dry skin, brittle nails, delayed ankle reflexes, and weight gain. These features suggest <strong>Hashimoto thyroiditis</strong> progressing to <strong>primary hypothyroidism</strong>.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202510011cdbd0b1-23d3-4212-ac6e-e76e748b2828.png\">\r\n<ul>\r\n<li><strong>Hashimoto thyroiditis</strong>is characterised by<strong> progressive destruction of thyroid tissue</strong> by <strong>antithyroid peroxidase antibodies</strong> and <strong>antithyroglobulin antibodies</strong>. Initially, it may manifest with transient hyperthyroidism before progressing to hypothyroidism.</li>\r\n<li>Hypothyroidism results in a generalised <strong>decrease of the basal metabolic rate</strong>, which can present with <strong>weight gain, fatigue, dry skin and brittle nails, along with concentration and memory impairment</strong>.</li>\r\n<li><strong>Treatment</strong>with<strong> Lifelong oral administration of L-thyroxine (T4)</strong>, commencing at a lower and more slow-acting dose, with increasing severity of hypothyroidism because of the risk of cardiac side effects.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Thiamine (Option A):</strong> Used in Wernicke encephalopathy and beriberi, not relevant here.</p>\r\n<p><strong>Vitamin B12 (Option B):</strong> Causes cognitive symptoms but usually includes anaemia, paresthesias, and gait abnormalities.</p>\r\n<p><strong>Rivastigmine (Option C):</strong> Cholinesterase inhibitor for Alzheimer's disease; not appropriate in this hypothyroid state.</p>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the dose</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Maintain same dose</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduce the dose</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Discontinue the drug</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman on L-thyroxine comes for follow-up with a TSH of 7 mU/L. Previous TSH level = 4.5 mU/L. No other complaints. What would you suggest?</span></p>",
      "unique_key": "DT1166375",
      "question_audio": null,
      "question_video": null,
      "map_id": 1166375,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>TSH elevation in a patient on L-thyroxine indicates under-replacement. The treatment goal is to titrate L-thyroxine dose to keep TSH within the normal range, especially in non-elderly patients without cardiovascular disease.</p>\r\n<ul>\r\n<li>A mild increase in TSH suggests <strong>subclinical hypothyroidism</strong>or insufficient hormone dose.</li>\r\n<li>L-thyroxine dose should be <strong>adjusted upward</strong>and TSH rechecked after 6&ndash;8 weeks.</li>\r\n<li>In the absence of symptoms, therapy is guided by <strong>biochemical values</strong>.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20251001d9a77370-cb2e-45ed-b896-cdf85b541be3.png\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240322f6cbf980-2d27-44d4-a764-eb7484d93977.jpg\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Maintain the same dose (Option B):</strong> Not appropriate since the patient's TSH has increased above the normal reference range (0.4-4.5 mU/L), indicating <strong>suboptimal therapy</strong>.</p>\r\n<p><strong>Reduce the dose (Option C):</strong> Incorrect, as a dose reduction would worsen hypothyroidism by further increasing TSH levels.</p>\r\n<p><strong>Discontinue the drug (Option D):</strong> Absolutely contraindicated; discontinuing L-thyroxine would lead to <strong>full-blown hypothyroidism</strong> with potential metabolic and cardiovascular complications.</p>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}